Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.

Détails

ID Serval
serval:BIB_9823686480AE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
Périodique
Kidney international
Auteur⸱e⸱s
Egli-Spichtig D., Imenez Silva P.H., Glaudemans B., Gehring N., Bettoni C., Zhang MYH, Pastor-Arroyo E.M., Schönenberger D., Rajski M., Hoogewijs D., Knauf F., Misselwitz B., Frey-Wagner I., Rogler G., Ackermann D., Ponte B., Pruijm M., Leichtle A., Fiedler G.M., Bochud M., Ballotta V., Hofmann S., Perwad F., Föller M., Lang F., Wenger R.H., Frew I., Wagner C.A.
ISSN
1523-1755 (Electronic)
ISSN-L
0085-2538
Statut éditorial
Publié
Date de publication
10/2019
Peer-reviewed
Oui
Volume
96
Numéro
4
Pages
890-905
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis, and its early rise in patients with chronic kidney disease is independently associated with all-cause mortality. Since inflammation is characteristic of chronic kidney disease and associates with increased plasma FGF23 we examined whether inflammation directly stimulates FGF23. In a population-based cohort, plasma tumor necrosis factor (TNF) was the only inflammatory cytokine that independently and positively correlated with plasma FGF23. Mouse models of chronic kidney disease showed signs of renal inflammation, renal FGF23 expression and elevated systemic FGF23 levels. Renal FGF23 expression coincided with expression of the orphan nuclear receptor Nurr1 regulating FGF23 in other organs. Antibody-mediated neutralization of TNF normalized plasma FGF23 and suppressed ectopic renal Fgf23 expression. Conversely, TNF administration to control mice increased plasma FGF23 without altering plasma phosphate. Moreover, in Il10-deficient mice with inflammatory bowel disease and normal kidney function, plasma FGF23 was elevated and normalized upon TNF neutralization. Thus, the inflammatory cytokine TNF contributes to elevated systemic FGF23 levels and also triggers ectopic renal Fgf23 expression in animal models of chronic kidney disease.
Mots-clé
bone, chronic kidney disease (CKD), cytokine, fibroblast growth factor 23 (FGF23), inflammation, inflammatory bowel disease, tumor necrosis factor (TNF)
Pubmed
Web of science
Création de la notice
22/07/2019 17:45
Dernière modification de la notice
08/10/2019 6:10
Données d'usage